A retrospective analysis of the “Neverending Trip” after administration of a potent full agonist of 5-HT2A receptor – 25I-NBOMe Posted on March 29, 2022 By Becky Carter Daria Schetz, Adriana Schetz, Ivan Kocić Biomed Pharmacother; 146; 2022 Access article Chemistry, Crime Scene Investigation and Reconstruction, DREs / Traffic Safety Resource Prosecutors, Seized Drugs/Controlled Substances, Toxicology